Rocket Pharmaceuticals Market Sentiment

Rocket Pharmaceuticals Inc

RCKTNASDAQ

Trade with Public

$2.29

-0.02-0.87%

最終更新: Oct 23, 4:55 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Rocket Pharmaceuticals Market Sentiment - Benzinga

Rocket Pharmaceuticals Market Sentiment

Market sentiment signals for Rocket Pharmaceuticals (RCKT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 16.8% short float

Options Flow▲ 0.05 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

17 analysts

Options Flow (P/C)

0.05

More calls — Bullish

301 calls · 14 puts

Avg Consensus PT

+284.6%

Highest Price Target

$19

+733.3%

Scotiabank

Lowest Price Target

+9.6%

Jefferies

Short Interest

16.8%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	Goldman Sachs	Richard Law—	+75.4%	$3 → $4	Upgrade	Sell→Neutral
Oct 7, 2026	Leerink Partners	Roanna Ruiz—	+75.4%	$7 → $4	Maintained	Market Perform
Oct 7, 2026	Wedbush	Yun Zhong—	+557.9%	$15 → $15	Maintained	Outperform
Oct 7, 2026	Chardan Capital	Keay Nakae—	+382.5%	$11 → $11	Maintained	Buy
Sep 16, 2026	Wedbush	Yun Zhong—	+557.9%	$15 → $15	Maintained	Outperform
Sep 16, 2026	Needham	Gil Blum—	+294.7%	$9	Upgrade	Hold→Buy
Sep 15, 2026	Chardan Capital	Keay Nakae—	+382.5%	$11 → $11	Maintained	Buy
Sep 1, 2026	Chardan Capital	Keay Nakae—	+382.5%	$11 → $11	Maintained	Buy
Aug 11, 2026	Wedbush	Yun Zhong—	+557.9%	$16 → $15	Maintained	Outperform
May 11, 2026	Chardan Capital	Geulah Livshits—	+382.5%	$11 → $11	Maintained	Buy
Mar 30, 2026	B of A Securities	Jason Zemansky—	+294.7%	$8 → $9	Maintained	Buy
Mar 27, 2026	Chardan Capital	Geulah Livshits—	+382.5%	$11 → $11	Maintained	Buy
Mar 2, 2026	Goldman Sachs	Richard Law—	+31.6%	$2 → $3	Maintained	Sell
Feb 27, 2026	Cantor Fitzgerald	Josh Schimmer—	+338.6%	$8 → $10	Maintained	Overweight
Nov 18, 2025	B of A Securities	Jason Zemansky—	+250.9%	$10 → $8	Maintained	Buy
Nov 18, 2025	JP Morgan	Tessa Romero—	+11435.1%	$261 → $263	Downgrade	Overweight→Underweight
Oct 14, 2025	Chardan Capital	Geulah Livshits—	+382.5%	$11 → $11	Maintained	Buy
Oct 3, 2025	Leerink Partners	Mani Foroohar—	+207.0%	$9 → $7	Maintained	Market Perform
Aug 20, 2025	B of A Securities	Jason Zemansky—	+338.6%	$4 → $10	Upgrade	Neutral→Buy
Aug 20, 2025	Chardan Capital	Geulah Livshits—	+382.5%	$11 → $11	Maintained	Buy
Aug 11, 2025	Chardan Capital	Geulah Livshits—	+382.5%	$12 → $11	Maintained	Buy
Aug 8, 2025	Cantor Fitzgerald	Josh Schimmer—	+250.9%	$10 → $8	Maintained	Overweight
Jul 25, 2025	B of A Securities	Jason Zemansky—	+75.4%	$9 → $4	Downgrade	Buy→Neutral
Jul 25, 2025	Canaccord Genuity	Whitney Ijem—	+338.6%	$11 → $10	Maintained	Buy
Jul 24, 2025	Chardan Capital	Geulah Livshits—	+426.3%	$17 → $12	Maintained	Buy